Skip to main content
Fig. 2 | Trials

Fig. 2

From: Efficacy and safety of Jian-Pi Huo-Xue granule for non-alcoholic fatty liver disease: study protocol for a randomized, double-blind, placebo-controlled trial

Fig. 2

Study schedule of enrolment, interventions, and assessments. Abbreviations: JPHX, Jian-Pi Huo-Xue granule; MRI-PDFF, magnetic resonance imaging - proton density fat fraction; BMI, body mass index; WHR, waist-to-hip ratio; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; FPG, fasting plasma glucose; FINS, fasting insulin; HOMA-IR, homeostasis model assessment - insulin resistance; SF-36, Medical Outcomes Study item short-form health survey; CLDQ, Chronic Liver Disease Questionnaire; NAFLD, non-alcoholic fatty liver disease; TCM, traditional Chinese medicine

Back to article page

Trials

ISSN: 1745-6215